摘要:
The present invention relates to compounds of formula (I), and pharmaceutically acceptable salts, solvates and prodrugs thereof: Formula (I) wherein Q is selected from O, S and Se; J is S or Se; W1 and W2, when present, are independently selected from N and C; R1 and R2 are independently selected from the group consisting of hydrogen, C1-C12alkyl, C2-C12alkenyl, C2-C12alkynyl, aryl, heterocyclyl, heteroaryl, cycloalkyl, cycloalkenyl, amino, amido, alkylthio, acyl, arylalkyl and acylamido, all of which may be optionally substituted; and wherein at least one of W1 and W2 is present and is a nitrogen atom and when R1 and R2 are cyclic then the respective W1 or W2 may form part of the ring structure. The present invention also relates to pharmaceutical compositions including such compounds, to methods of treatment using such compounds, in particular in relation to NLRP3 inflammasome mediated disorders, and to associated diagnostic uses.
摘要:
Embodiments in accordance with the present invention provide forming various polycycloalkyl polynorbornene polymers and copolymers which are useful for forming pervaporation membranes, the membranes themselves and methods of making such membranes.
摘要:
A monobenzochrysene derivative shown by the following formula (1):
wherein R 1 to R 14 are independently a hydrogen atom or a substituent, and at least one of R 1 to R 14 is a substituted or unsubstituted aryl group having 6 to 50 ring carbon atoms which does not contain an anthracene skeleton and a benzo[g]chrysene skeleton or a substituted or unsubstituted heteroaryl group having 5 to 50 ring carbon atoms which does not contain an anthracene skeleton and a benzo[g]chrysene skeleton, excluding the case where R 8 and R 9 are unsubstituted phenyl groups and R 1 to R 7 and R 10 to R 14 are hydrogen atoms and the case where R 9 is an unsubstituted phenyl group and R 1 to R 8 and T 10 to R 14 are hydrogen atoms.
摘要:
The invention relates to 1,2,3,6,7,8-hexahydro-s-indacene-derivatives and 6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-derivatives of formula (I), wherein R1, A1, Z1, n, X and Y have the meaning defined in the claims. The invention also relates to the use thereof as component(s) in liquid-crystal substances. The invention further relates to liquid-crystal and electro-optical display elements which contain the inventive liquid-crystal substances.
摘要:
This invention pertains generally to prostacyclin analogs and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis. Generally, the compounds and methods of the present invention increase the oral bioavailability and circulating concentrations of treprostinil when administered orally. Compounds of the present invention have formula (I).
摘要:
A novel series of polycyclic amine derivatives, of formula I methods of making the compounds, novel intermediates, compositions containing them, and pharmaceutical compositions useful in the treatment and prevention of cerebrovascular disorders and useful as anesthetics or analgesics.
摘要:
Disclosed are new conjugated compounds (e.g., monomers and polymers) that include ladder-type moieties which can be used for preparing semiconducting materials. Such conjugated compounds can exhibit high n-type carrier mobility and/or good current modulation characteristics. Compounds of the present teachings also can exhibit ambipolar semiconducting activity. In addition, the compounds of the present teachings can possess certain processing advantages such as solution- processability and/or good stability in ambient conditions.
摘要:
The invention relates to 1,2,3,6,7,8-hexahydro-s-indacene-derivatives and 6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-derivatives of formula (I), wherein R1, A1, Z1, n, X and Y have the meaning defined in the claims. The invention also relates to the use thereof as component(s) in liquid-crystal substances. The invention further relates to liquid-crystal and electro-optical display elements which contain the inventive liquid-crystal substances.